fbpx
Medical Innovation Exchange

GSK strikes $3.3B Affinivax buyout to MAP out challenge to Pfizer's blockbuster pneumococcal vaccine

https://www.fiercebiotech.com/biotech/gsk-strikes-21b-affinivax-buyout-map-out-challenge-blockbuster-pfizer-vaccine

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.